Cantel Medical (CMD) Forecast, Price Target & Analyst Ratings

NYSEARCA:CMD

80.37
-0.96 (-1.18%)
At close: Jun 1, 2021
80.37
0 (0%)
After Hours: 6/1/2021, 8:24:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Cantel Medical (CMD).

Forecast Snapshot

Consensus Price Target

Price Target
$63.24
-21.31% Downside

Next Earnings Forecast

Earnings Estimate
Release DateN/A
PeriodQ3 / 2021
EPS Estimate$0.70
Revenue Estimate306.921M

ChartMill Buy Consensus

Rating
65.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$63.24
Upside
-21.31%
From current price of $80.37 to mean target of $63.24, Based on 4 analyst forecasts
Low
$62.62
Median
$63.24
High
$65.10

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CMD Current Analyst RatingCMD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

CMD Historical Analyst RatingsCMD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
65.00%
CMD was analyzed by 4 analysts. The buy percentage consensus is at 65. So analysts seem to be rather neutral about CMD.
In the previous month the buy percentage consensus was at a similar level.
Only 4 analysts analyzed CMD. So this is just the average opinion of a couple of analysts.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release DateN/A
PeriodQ3 / 2021
EPS Estimate$0.70
Revenue Estimate306.921M
Revenue Q2Q35.21%
EPS Q2Q339.98%
Number of Analysts5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
CMD revenue by date.CMD revenue by date.
N/AN/A
18.79%		N/A
15.19%		N/A
13.63%		N/A
5.57%		N/A
9.85%		N/A
17.48%		N/A
6.70%		N/A
7.57%		N/A
5.55%		N/A
7.13%
EBITDA
YoY % growth
CMD ebitda by date.CMD ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CMD ebit by date.CMD ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
CMD operating margin by date.CMD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CMD eps by date.CMD eps by date.
N/AN/A
25.55%		1.91
32.71%		2.50
30.89%		2.37
-5.20%		1.66
-29.96%		N/A
82.92%		N/A
3.37%		N/A
15.75%		N/A
8.47%		N/A
9.56%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23
EPS
Q2Q % growth		0.70
339.98%		0.69
188.27%		0.68
-23.91%		0.71
-10.63%		0.85
20.09%		0.78
12.55%		0.77
12.54%		0.79
12.16%		0.94
10.63%
Revenue
Q2Q % growth		306.921M
35.21%		323.277M
13.82%		317.796M
13.18%		323.074M
8.56%		334.341M
8.93%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CMD Yearly Revenue VS EstimatesCMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CMD Yearly EPS VS EstimatesCMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
29.83%
EPS Next 5 Year
21.07%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.48%
Revenue Next 5 Year
8.80%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Cantel Medical / CMD Forecast FAQ

What is the price target for CMD stock?

4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37.


Can you provide the consensus estimates for Cantel Medical next earnings?

The consensus EPS estimate for the next earnings of Cantel Medical (CMD) is 0.7 null and the consensus revenue estimate is 306.92M null.


Can you provide the analyst count for Cantel Medical stock?

The number of analysts covering Cantel Medical (CMD) is 4.